URSO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 633
AS - Asia 368
EU - Europa 334
SA - Sud America 8
OC - Oceania 4
AF - Africa 2
Totale 1.349
Nazione #
US - Stati Uniti d'America 614
SG - Singapore 211
IT - Italia 182
CN - Cina 53
ID - Indonesia 45
DE - Germania 41
FI - Finlandia 34
GB - Regno Unito 32
CA - Canada 19
IN - India 14
VN - Vietnam 12
BE - Belgio 11
LT - Lituania 10
HK - Hong Kong 8
TH - Thailandia 8
SE - Svezia 7
CZ - Repubblica Ceca 5
IR - Iran 5
KR - Corea 5
NL - Olanda 5
AU - Australia 4
BR - Brasile 4
AR - Argentina 2
CO - Colombia 2
EG - Egitto 2
MY - Malesia 2
RO - Romania 2
TR - Turchia 2
AT - Austria 1
ES - Italia 1
JP - Giappone 1
PH - Filippine 1
PT - Portogallo 1
RU - Federazione Russa 1
TW - Taiwan 1
UA - Ucraina 1
Totale 1.349
Città #
Santa Clara 215
Singapore 169
Chandler 60
Jakarta 45
Shanghai 36
New York 30
Milan 27
Ashburn 26
Helsinki 23
Ferrara 22
Fairfield 18
London 17
Frankfurt am Main 16
Munich 14
Bologna 13
Dong Ket 12
Los Angeles 12
Lappeenranta 11
Houston 10
Ottawa 10
Brussels 9
Toronto 9
Boardman 8
Buriram 8
Hong Kong 8
Parma 8
Wilmington 7
Cambridge 6
Ferrara di Monte Baldo 6
Princeton 6
Rome 6
Bremen 5
Brno 5
Poggio Renatico 5
San Diego 5
Woodbridge 5
Lizzano in Belvedere 4
Monza 4
Rovigo 4
Seattle 4
Sydney 4
Addison 3
Ann Arbor 3
Chicago 3
Copparo 3
Florence 3
Hounslow 3
Isfahan 3
Kochi 3
Alpharetta 2
Brasília 2
Cairo 2
Chandigarh 2
Cipolletti 2
Dej 2
Forlì 2
Incheon 2
Istanbul 2
Knoxville 2
Kuala Lumpur 2
Maglie 2
Medellín 2
Molfetta 2
Occhiobello 2
Padova 2
Pelotas 2
Reggio Emilia 2
Sala Baganza 2
Sandston 2
Santa Cruz 2
Turnhout 2
Agrate Conturbia 1
Alzano Lombardo 1
Amsterdam 1
Atlanta 1
Barletta 1
Bhubaneswar 1
Cameri 1
Changzhou 1
Cheongju-si 1
Clifton 1
Delhi 1
Edison 1
Falls Church 1
Fuzhou 1
Indore 1
Kilburn 1
Leawood 1
Lisbon 1
Madrid 1
Moscow 1
New Bedfont 1
Nuremberg 1
Paderno Dugnano 1
Palermo 1
Pavia 1
Portomaggiore 1
Seodaemun-gu 1
Sona 1
Southwark 1
Totale 1.009
Nome #
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 101
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 72
Clinical-diagnostic relevance of breast “incidentaloma” detected during 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: Correlation with radiological imaging and histopathology 61
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 56
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 48
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report 48
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 44
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? 44
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives 43
Uncommon solitary nasal extramedullary plasmacytoma detected by 18F-FDG PET/CT 41
Considerations on the preliminary results of the NETTER-2 trial: is the glass half full or half empty? 39
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 37
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer 35
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 31
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma 29
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 29
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature 28
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review 28
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 27
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 26
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach 26
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 25
Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia 24
[18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake 23
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer 22
COMPARISON BETWEEN CLINICAL DOSIMETRIC PLATFORMS IN NET PATIENTS TREATED WITH PRRT 21
68Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade Tumors 21
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 20
Incidental findings of acute myeloid leukemia in Sjögren's syndrome detected by nuclear medicine techniques 20
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 19
Cavernous Hepatic Hemangioma at 18F‑Choline Positron Emission Tomography–Computed Tomography: Be Aware of the Pitfall 18
18 F-Choline Versus 68 Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma 18
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives 18
[18F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review 17
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement 17
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 16
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 15
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 15
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 14
Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000-2022) 14
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 14
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors 14
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 14
Complicated Inguinal Hernia Incidentally Detected on a Radiolabelled Autologous White Blood Cell Scan 14
Clinical applications of long axial field-of-view PET/CT scanners in oncology 14
[99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol 13
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 13
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 13
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review 13
Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis 13
Molecular imaging of PARP in cancer: state-of-the-art 12
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma - Today's impact, tomorrow's potential 11
The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria 11
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine? 10
Is There a Role for FAPI PET in Urological Cancers? 10
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 10
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 9
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art 9
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 8
Extramedullary disease in multiple myeloma: what you might not expect on [18F]FDG PET/CT - a pictorial essay 7
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health 6
Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when? 6
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview 5
The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective 4
Radioligand therapy in sympathetic-adrenal-medullary axis tumors: state of art and perspectives 4
Totale 1.507
Categoria #
all - tutte 14.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 0 1 32 1 5 0 5 1 18
2021/202261 2 0 0 2 5 4 7 2 5 3 15 16
2022/2023186 7 15 3 17 21 20 18 18 14 2 42 9
2023/2024371 11 24 29 14 40 45 12 47 18 12 40 79
2024/2025826 74 87 190 104 235 136 0 0 0 0 0 0
Totale 1.507